Drug
Nepicastat
Nepicastat: highest development phase Phase 2, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nepicastat NCT00659230 | Phase 2 | Posttraumatic Stress Disorder |
Latest
No recent events.
Follow Nepicastat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.